Printer Friendly

DURAMED EXPECTS CONTINUED IMPROVEMENT IN FOURTH QUARTER

 CINCINNATI, Jan. 11 /PRNewswire/ -- E. Thomas Arington, chairman and president of Duramed Pharmaceuticals, Inc. (OTC: DRMD) announced today that he expects results for the fourth quarter ended Dec. 31, 1993, to show continued improvement in sales and profits. "This improvement is expected to be greater than any previous quarter-to-quarter improvements reported for 1993. We expect the year-end audit to be completed in March and final results for the fourth quarter and year-end to be released at that time."
 Duramed Pharmaceuticals, Inc. manufactures and sells generic drug products comprised of various dosages of prescription and over-the- counter drugs. The company's stock is traded on the OTC Bulletin Board under the symbol DRMD.
 /CONTACT: E. Thomas Arington, chairman and chief executive officer, or Timothy J. Holt, vice president-finance, of Duramed Pharmaceuticals,


513-731-9900/
 (DRMD)


CO: Duramed Pharmaceuticals, Inc. ST: Ohio IN: MTC SU: ERP

KL-CM -- CL009 -- 0919 01/11/94 10:36 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 11, 1994
Words:150
Previous Article:DELTA CONNECTION, COMAIR ANNOUNCES INTRODUCTORY FARES ON NEW WICHITA, KANSAS SERVICE
Next Article:RF&P TO PURCHASE FOUR BUILDINGS AT THE ARBORETUM OFFICE PARK IN CHESTERFIELD COUNTY
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters